Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Jun 25, 16:00
Sinovac Biotech Revenue (Annual): 448.27M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 448.27M |
| December 31, 2022 | 1.493B |
| December 31, 2021 | 19.37B |
| December 31, 2020 | 510.62M |
| December 31, 2019 | 246.05M |
| December 31, 2018 | 229.65M |
| December 31, 2017 | 174.35M |
| December 31, 2016 | 72.43M |
| December 31, 2015 | 67.41M |
| December 31, 2014 | 62.93M |
| December 31, 2013 | 71.77M |
| December 31, 2012 | 49.22M |
| Date | Value |
|---|---|
| December 31, 2011 | 56.84M |
| December 31, 2010 | 33.40M |
| December 31, 2009 | 84.20M |
| December 31, 2008 | 46.50M |
| December 31, 2007 | 33.54M |
| December 31, 2006 | 15.35M |
| December 31, 2005 | 8.608M |
| December 31, 2004 | 6.454M |
| December 31, 2003 | 2.839M |
| April 30, 2002 | 0.5192M |
| April 30, 2001 | 0.3185M |
| April 30, 2000 | 0.0014M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
246.05M
Minimum
2019
19.37B
Maximum
2021
4.415B
Average
510.62M
Median
2020
Revenue (Annual) Benchmarks
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| China SXT Pharmaceuticals Inc | 1.972M |
| Adagene Inc | 18.11M |
| LakeShore Biopharma Co Ltd | 100.37M |